Form 8-K - Current report:
SEC Accession No. 0001493152-24-033762
Filing Date
2024-08-23
Accepted
2024-08-23 17:15:20
Documents
18
Period of Report
2024-08-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57143
2 ex10-1.htm EX-10.1 20150
3 ex99-1.htm EX-99.1 16467
4 ex10-1_001.jpg GRAPHIC 3181
5 ex_001.jpg GRAPHIC 39475
  Complete submission text file 0001493152-24-033762.txt   396544

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE biaf-20240819.xsd EX-101.SCH 3769
7 XBRL DEFINITION FILE biaf-20240819_def.xml EX-101.DEF 28234
8 XBRL LABEL FILE biaf-20240819_lab.xml EX-101.LAB 37745
9 XBRL PRESENTATION FILE biaf-20240819_pre.xml EX-101.PRE 26446
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7149
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 241237218
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)